Pamela Pavco

2012 - RXi Pharmaceuticals

In 2012, Pamela Pavco earned a total compensation of $2M as Chief Development Officer at RXi Pharmaceuticals, a 407% increase compared to previous year.

Compensation breakdown

Bonus$90,000
Option Awards$1,590,561
Salary$300,000
Other$275
Total$1,980,836

Pavco received $1.6M in option awards, accounting for 80% of the total pay in 2012.

Pavco also received $90K in bonus, $300K in salary and $275 in other compensation.

Rankings

In 2012, Pamela Pavco's compensation ranked 3,596th out of 11,487 executives tracked by ExecPay. In other words, Pavco earned more than 68.7% of executives.

ClassificationRankingPercentile
All
3,596
out of 11,487
69th
Division
Manufacturing
1,238
out of 4,253
71st
Major group
Chemicals And Allied Products
276
out of 1,198
77th
Industry group
Drugs
162
out of 920
82nd
Industry
Pharmaceutical Preparations
127
out of 700
82nd
Source: SEC filing on April 15, 2014.

Pavco's colleagues

We found two more compensation records of executives who worked with Pamela Pavco at RXi Pharmaceuticals in 2012.

2012

Geert Cauwenbergh

RXi Pharmaceuticals

Chief Executive Officer

2012

Anastasia Khvorova

RXi Pharmaceuticals

Chief Scientific Officer

In-depth

You may also like